Sign in
Taking people in United StatesNo phase

Blood vessel health in adults with Down syndrome

Looks at how well blood vessels work in adults with Down syndrome.

Key facts

Who runs it
University of Nevada, Las Vegas
Where
Las Vegas, United StatesSee the site
Trial code
Registry title
Vascular Function in Adults With Down Syndrome
Status
Recruiting
People taking part
46 people, planned
Started
9 Apr 2026
Expected to end
31 Dec 2027
Type of study
Observational, 2 groups
Record updated
2 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for generally healthy, inactive adults with Down syndrome and adults without Down syndrome of the same age and sex. It studies how well blood vessels work.

Age
18 to 35 years
Sex
All sexes
Disease stage
People with Down syndrome must have a diagnosis of Down syndrome trisomy 21. Their thyroid function must be normal, or stable (with stable medicines) for at least 6 months. All people must be generally healthy and inactive: less than 30 minutes of moderate physical activity per day.
Earlier treatment
People cannot join if they take heart medicines that affect heart rate, blood pressure or artery function, blood thinners, or anti-inflammatory medicines such as NSAIDS.

Main reasons for not taking part

  • Heart problem from birth that has not been fixed, or blood vessel disease, blood clots or clotting disorders
  • Asthma or other lung disease
  • Blood pressure above 140/90 mmHg or below 90/60 mmHg, or past fainting or near-fainting
  • Diabetes (HbA1c >7.5% (58 mmol/mol) or using sugar-lowering medicine), or BMI >40
  • Current smoking, pregnancy, plans to get pregnant, breastfeeding, or not willing to use birth control

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • between 18 and 35 years old
  • generally healthy
  • sedentary (defined as being involved in less than 30 minutes of moderately-intense physical activity per day); Additionally, for the participants with Down syndrome:
  • diagnosis of Down syndrome trisomy 21
  • normal thyroid function or stable thyroid function (and medications) for at least 6 months

Who cannot take part

  • unresolved congenital heart disease
  • atherosclerotic or other vascular disease (such as blood clot history or clotting disorders)
  • asthma or other pulmonary disease
  • hypertension (defined as BP >140/90 mmHg); blood pressure below 90/60 mmHg
  • history of pre-syncope or syncope
  • heart medications affecting heart rate, blood pressure, or arterial function, including blood thinners; anti-inflammatory medication, including Nonsteroidal anti-inflammatory drugs (NSAIDS)
  • diabetes (defined as glycated hemoglobin (HbA1c) of >7.5% or use of glucose-lowering medication)
  • severe obesity (defined as body mass index (BMI) >40)
  • current smoking
  • currently pregnant or planning to become pregnant during the study period
  • currently breastfeeding
  • unable or unwilling to use an acceptable method of contraception during the study timeframe
  • positive pregnancy test at screening

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 35 years old?

Where in United States

  • University of Nevada Las Vegas - UNLVLas Vegas, United StatesContact: Thessa Hilgenkamp, PhDTaking people

About the trial

What the trial wants to find out

Adults with Down syndrome (Ds) are often thought to have a lower risk of heart and blood vessel disease because they tend to have lower blood pressure (BP) and fewer heart attacks than people without Ds. However, recent research suggests that heart and blood vessel diseases, including stroke, are becoming a more common cause of death in adults with Ds as life expectancy increases. Despite these findings, studies examining heart and blood vessel health in adults with Ds have produced mixed results, making it difficult to determine their true risk and whether preventive strategies are needed. This study will investigate the health of blood vessels in adults with Ds and compare the results with those of adults without Ds. Healthy blood vessels are important because they help deliver blood and oxygen throughout the body. Changes in blood vessel function and stiffness can occur with aging and may increase the risk of heart disease, stroke, kidney disease, and memory problems. The study aims to determine whether adults with Ds experience changes in blood vessel health that may place them at increased cardiovascular risk. Specifically, the study will: (1) Examine how well blood vessels function in adults with Ds; (2) Measure the stiffness of arteries in adults with Ds; (3) Compare two methods used to assess blood vessel function to determine whether a simpler exercise-based test provides results similar to a commonly used standard test. The findings may improve understanding of cardiovascular risk in adults with Ds and help guide future strategies to promote healthy aging in this population.

The 2 groups in the trial

  • Down Syndrome

    Adults with Down Syndrome

  • Control group

    Age- and sex-matched adults without Down Syndrome

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Vascular Function in Adults With Down Syndrome
Plain-language title
Blood vessel health in adults with Down syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07630207, who can take part
Record updated
2 October 2026